Most Clicked StoriesMore >


Lantheus, GE Healthcare collaborate on F-18 flurpiridaz PET agent development

SNMMI SmartBrief | Feb 22, 2017

Lantheus Medical Imaging has entered a development and commercialization agreement with GE Healthcare for its F-18 flurpiridaz PET agent for myocardial perfusion imaging. The radiotracer's second late-stage trial, global regulatory approvals and commercialization will be funded by GE, while Lantheus will participate in development and commercialization via a joint steering panel and maintain a co-promotion option in the US. Seeking Alpha (free registration) (02/21)


Research suggests fibromyalgia is a spectrum disorder

SNMMI SmartBrief | Feb 23, 2017

Expert offers insights on Medicare coverage for oncologic PET radiotracers

SNMMI SmartBrief | Feb 20, 2017

Cardiovascular benefits seen in periodic fasting diet

SNMMI SmartBrief | Feb 22, 2017

PET, fMRI shed light on link between dopamine, human bonding

SNMMI SmartBrief | Feb 21, 2017

Speech deficits may be early signs of Alzheimer's disease

SNMMI SmartBrief | Feb 22, 2017

Study IDs molecular link between high blood sugar, Alzheimer's disease

SNMMI SmartBrief | Feb 24, 2017

Study evaluates additional rituximab dose in Hodgkin lymphoma

SNMMI SmartBrief | Feb 23, 2017

Triple combo regimen found effective as first-line myeloma treatment

SNMMI SmartBrief | Feb 20, 2017

USP to post second round of public comments for General Chapter <797>

SNMMI SmartBrief | Feb 20, 2017


Find SNMMI SmartBrief Issues by Date:



SNMMI News More >


Watch a special video invitation from the SNMMI president

SNMMI SmartBrief | Feb 24, 2017

Review essential topics in nuclear medicine

SNMMI SmartBrief | Feb 24, 2017

Mark your calendar for the 2017 Clinical Trials Network (CTN) Webinar Series

SNMMI SmartBrief | Feb 23, 2017

Build your schedule for SNMMI's 2017 Annual Meeting

SNMMI SmartBrief | Feb 23, 2017

Deadlines approach for six grant/award opportunities

SNMMI SmartBrief | Feb 22, 2017




Sign up for SNMMI SmartBrief



Designed specifically for nuclear medicine and molecular imaging professionals, SNMMI SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news and information to save you time and keep you informed on our profession. Learn more